Shibani Sunilkumar Shah

Shibani Shah practices at P. James Voloshin M.D., Inc in Newport Beach, California.

Shibani Shah's NPI, 1326719063, was assigned on September 22, 2021. Shibani Shah holds California license 95018730.

Shibani Shah's primary practice is P. James Voloshin M.D., Inc, at 360 San Miguel Dr, Newport Beach, CA 92660 in Orange County. The practice phone is (949) 759-0995.

Shibani Shah's primary practice is P. James Voloshin M.D., Inc in Newport Beach, California. The medical group on file is Schweiger Dermatology Group, San Pedro. Dmand AI also links Shibani Shah to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Shibani Shah practices, 4 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Shibani Shah's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Shibani Shah is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, eyelid inflammation, hives and itchy rashes among the conditions Shibani Shah treats.

CMS data shows 682 Medicare services from Shibani Shah across 9 procedure codes in 2024, for 142 Medicare patients. Medicare paid $22,444 for them. Every service was in an office.

CMS counts 142 Medicare patients who saw Shibani Shah in 2024. The largest group is 65 to 74, with 76 patients. 75% of them have high cholesterol, and 63% have high blood pressure. Their average risk score is 0.94, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Shibani Shah's median patient age at 46, with 59% women.

In 2024, Shibani Shah wrote 282 Medicare Part D claims for 116 patients. 96% of them were for generic drugs. CMS names the drug for 218 of them, across 6 drugs with 11 or more claims each, at $3,088 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Shibani Shah for performance year 2024, reported as part of a group. Shibani Shah accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 128 general payments to Shibani Shah from 22 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 82% of the total. Arcutis Biotherapeutics, Inc. paid the most, $1,173.